Semax: The ACTH-Derived Peptide for Peak Cognitive Performance

Semax is a synthetic heptapeptide derived from the N-terminal fragment of adrenocorticotropic hormone (ACTH 4-10), with an added C-terminal tripeptide sequence (Pro-Gly-Pro) that confers metabolic stability and enhanced neurotrophic activity. Originally developed at the Institute of Molecular Genetics in Moscow, Semax has been approved in Russia for the treatment of stroke, cognitive disorders, and optic nerve disease.

The primary mechanism through which Semax enhances cognition is the upregulation of brain-derived neurotrophic factor (BDNF) and its receptor TrkB. BDNF is the most abundant neurotrophin in the adult brain and is critical for long-term potentiation, the synaptic process underlying learning and memory. Studies demonstrate that Semax administration increases BDNF mRNA expression in the hippocampus and prefrontal cortex by 150-300 percent within hours of administration.

Semax also modulates the expression of nerve growth factor (NGF) and glial cell line-derived neurotrophic factor (GDNF), creating a multi-axis neurotrophic environment that supports neuronal survival, dendritic branching, and synaptogenesis. This broad neurotrophic profile distinguishes Semax from single-target nootropics and positions it as a comprehensive neuronal support compound.

Beyond neurotrophic effects, Semax demonstrates significant influence on monoamine neurotransmission. It modulates dopaminergic and serotonergic systems, contributing to enhanced motivation, mood stability, and sustained attention. Users consistently report improved focus, faster information processing, and greater resilience to mental fatigue, particularly during demanding cognitive tasks.

Clinical administration is intranasal, with typical doses ranging from 200-600 micrograms per day. The intranasal route ensures rapid central nervous system penetration. Treatment courses typically last 10-14 days with intervening rest periods, though chronic low-dose protocols are employed in some clinical settings. Semax has an excellent safety profile with no reported dependence, tolerance, or significant adverse effects. For individuals pursuing peak cognitive performance within a longevity framework, Semax offers a well-characterized, clinically validated tool for optimizing brain function.